Acadia Healthcare Company Inc (NASDAQ:ACHC) has received an average recommendation of “Hold” from the fourteen brokerages that are currently covering the company, Marketbeat Ratings reports. Two research analysts have rated the stock with a sell recommendation, eight have assigned a hold recommendation and three have issued a buy recommendation on the company. The average twelve-month price objective among analysts that have updated their coverage on the stock in the last year is $37.20.

A number of equities analysts have issued reports on the stock. BidaskClub downgraded shares of Acadia Healthcare from a “sell” rating to a “strong sell” rating in a report on Wednesday, March 27th. TheStreet downgraded shares of Acadia Healthcare from a “c” rating to a “d” rating in a report on Friday, March 1st. Robert W. Baird cut their price objective on shares of Acadia Healthcare from $40.00 to $38.00 and set a “neutral” rating on the stock in a report on Monday, March 4th. Citigroup cut their price objective on shares of Acadia Healthcare from $43.00 to $38.00 and set a “buy” rating on the stock in a report on Monday, March 4th. Finally, Zacks Investment Research raised shares of Acadia Healthcare from a “hold” rating to a “buy” rating and set a $30.00 price objective on the stock in a report on Monday, February 18th.

ACHC opened at $29.31 on Tuesday. The company has a current ratio of 1.08, a quick ratio of 1.08 and a debt-to-equity ratio of 1.35. The firm has a market cap of $2.59 billion, a price-to-earnings ratio of 13.08, a PEG ratio of 1.66 and a beta of 0.67. Acadia Healthcare has a 1 year low of $24.27 and a 1 year high of $45.35.

Several large investors have recently modified their holdings of the stock. Vanguard Group Inc boosted its holdings in shares of Acadia Healthcare by 2.5% in the 3rd quarter. Vanguard Group Inc now owns 7,399,082 shares of the company’s stock worth $260,447,000 after buying an additional 183,698 shares during the last quarter. Vanguard Group Inc. boosted its holdings in shares of Acadia Healthcare by 2.5% in the 3rd quarter. Vanguard Group Inc. now owns 7,399,082 shares of the company’s stock worth $260,447,000 after buying an additional 183,698 shares during the last quarter. JPMorgan Chase & Co. boosted its holdings in shares of Acadia Healthcare by 3.5% in the 3rd quarter. JPMorgan Chase & Co. now owns 6,033,366 shares of the company’s stock worth $212,375,000 after buying an additional 204,401 shares during the last quarter. Dimensional Fund Advisors LP boosted its holdings in shares of Acadia Healthcare by 3.3% in the 4th quarter. Dimensional Fund Advisors LP now owns 5,591,881 shares of the company’s stock worth $143,767,000 after buying an additional 176,791 shares during the last quarter. Finally, Elliott Management Corp purchased a new position in shares of Acadia Healthcare in the 4th quarter worth about $83,558,000.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities, and outpatient behavioral healthcare facilities to serve the behavioral health and recovery needs of communities. The company operates acute inpatient psychiatric facilities, which offer evaluation and crisis stabilization of patients with severe psychiatric diagnoses; specialty treatment facilities, including residential recovery facilities, eating disorder facilities, and comprehensive treatment centers that provide continuum care for adults with addictive disorders and co-occurring mental disorders; and residential treatment centers, which treat patients with behavioral disorders in a non-hospital setting, including outdoor programs.

Featured Story: What is the Book Value of a Share?

Analyst Recommendations for Acadia Healthcare (NASDAQ:ACHC)

Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.